title: Transplantation of allogeneic CD34+ blood cells in leukemia or lymphoma patients at high risk of GVHD.
authors.forename: F
authors.initials: F
authors.lastname: Viret
authors.forename: C
authors.initials: C
authors.lastname: Chabannon
authors.forename: T
authors.initials: T
authors.lastname: Aurran-Schleinitz
authors.forename: D
authors.initials: D
authors.lastname: Reviron
authors.forename: A M
authors.initials: AM
authors.lastname: Stoppa
authors.forename: C
authors.initials: C
authors.lastname: Faucher
authors.forename: P
authors.initials: P
authors.lastname: Ladaique
authors.forename: J A
authors.initials: JA
authors.lastname: Gastaut
authors.forename: D
authors.initials: D
authors.lastname: Maraninchi
authors.forename: D
authors.initials: D
authors.lastname: Blaise
mesh_terms: D000328:Adult; D018952:Antigens, CD34; D005260:Female; D006086:Graft vs Host Disease / Q000276:immunology*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000276:immunology* / Q000628:therapy*; D008223:Lymphoma / Q000276:immunology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous
chemical_list: D018952:Antigens, CD34